immunobiotics inc (IMBI:OTC US)

Last $0.03 USD
Change Today 0.00 / 0.00%
Volume 0.0
IMBI On Other Exchanges
Symbol
Exchange
IMBI:US
OTC US
As of 4:30 PM 03/11/13 All times are local (Market data is delayed by at least 15 minutes).

immunobiotics inc (IMBI) Snapshot

Open
--
Previous Close
$0.03
Day High
--
Day Low
--
52 Week High
05/24/12 - $0.10
52 Week Low
03/8/13 - $0.03
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
$-0.03
Shares Outstanding
23.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMMUNOBIOTICS INC (IMBI)
IMBI:US Historical Stock Quote
IMBI:US Advanced Stock Chart

Related News

No related news articles were found.

immunobiotics inc (IMBI) Related Businessweek News

No Related Businessweek News Found

immunobiotics inc (IMBI) Details

ImmunoBiotics, Inc., a development stage company, engages in licensing the manufacture, distribution, and sale of nutraceutical products that are made of naturally occurring dietary substances. It licenses LutiMax line of products, including LutiMax 10mg tablets, LutiMax 100mg Lozenges, and LutiSyn Capsules for human consumption and a powder for canine consumption; and LutiSport line of products comprising a lozenge for human consumption, as well as a powder for canine consumption. The company was formerly known as Multinational Merger Corporation and changed its name to ImmunoBiotics, Inc. in August 2007. ImmunoBiotics, Inc. was founded in 2004 and is based in San Clemente, California.

1 Employees
Last Reported Date: 04/15/10
Founded in 2004

immunobiotics inc (IMBI) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IMBI:US $0.03 USD 0.00

IMBI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IMBI.
View Industry Companies
 

Industry Analysis

IMBI

Industry Average

Valuation IMBI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 55.2x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 33.1x
View Detailed IMBI Financials

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IMMUNOBIOTICS INC, please visit www.immunobiotics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.

Close